• 2024 revenue up 18.9 per cent to £26.6mn
• Adjusted cash profit up 26 per cent to £6.2mn
• Underlying pre-tax profit of £4.3mn
• Post year-end disposals
Aim-traded Venture Life (VLG:55p), a developer of self-care products, is transitioning into a pure-play consumer healthcare platform focusing on products that support proactive, healthy longevity.
The group is streamlining its operations and selling its lower-margin, capital-intensive operations for €62mn (£53mn). These businesses generated a cash profit of £4.9mn and pre-tax profit of £0.9mn from revenue of £20.5mn in the 2024 financial year, so are being sold on a cash profit multiple of 11 times.